Full Press Release Details
Announces Peter Gray to Retire from ICON Board of Directors
DUBLIN--(BUSINESS WIRE)--June 12, 2012--ICON plc,
(NASDAQ:ICLR)(ISIN:IE0005711209) , a global provider of outsourced
development services to the pharmaceutical, biotechnology and medical
device industries, today announced that Vice Chairman, Mr. Peter Gray,
has decided to retire at the company's Annual General Meeting on the 19th
Commenting on the announcement, ICON plc Chairman, Dr. Bruce Given,
said: "Having facilitated a smooth transition since his retirement as
CEO in October 2011, Peter has decided not to stand for re-election to
the Board at our Annual General Meeting and to retire from the Board.
Peter led ICON through a period of industry-leading growth and I would
like to express our thanks and appreciation to Peter for his many
contributions to ICON and to convey the Board's best wishes to him for
DISCLOSURE NOTICE: The information contained in this release is
as of June 12th 2012. ICON assumes no obligation to update
forward-looking statements contained in this release. A description of
risks and uncertainties relating to ICON and its business can be found
in ICON's Annual Report and Form 20-F for the fiscal year ended December
31, 2011 and in its Reports of Foreign Issuer on Form 6-K filed with the
US Securities and Exchange Commission.
ICON plc is a global provider of outsourced development services to the
pharmaceutical, biotechnology and medical device industries. The Company
specialises in the strategic development, management and analysis of
programs that support clinical development - from compound selection to
Phase I-IV clinical studies. ICON currently has approximately 8,800
employees, operating from 84 locations in 40 countries.
Further information is available at www.iconplc.com